200 related articles for article (PubMed ID: 22319003)
1. Regulation of CCL20 expression in astrocytes by IL-6 and IL-17.
Meares GP; Ma X; Qin H; Benveniste EN
Glia; 2012 May; 60(5):771-81. PubMed ID: 22319003
[TBL] [Abstract][Full Text] [Related]
2. IL-6 trans-signaling enhances CCL20 production from IL-1β-stimulated human periodontal ligament cells.
Hosokawa Y; Shindo S; Hosokawa I; Ozaki K; Matsuo T
Inflammation; 2014 Apr; 37(2):381-6. PubMed ID: 24081898
[TBL] [Abstract][Full Text] [Related]
3. IL-17 enhancement of the IL-6 signaling cascade in astrocytes.
Ma X; Reynolds SL; Baker BJ; Li X; Benveniste EN; Qin H
J Immunol; 2010 May; 184(9):4898-906. PubMed ID: 20351184
[TBL] [Abstract][Full Text] [Related]
4. Raloxifene suppresses experimental autoimmune encephalomyelitis and NF-κB-dependent CCL20 expression in reactive astrocytes.
Li R; Xu W; Chen Y; Qiu W; Shu Y; Wu A; Dai Y; Bao J; Lu Z; Hu X
PLoS One; 2014; 9(4):e94320. PubMed ID: 24722370
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 (IL-6) production by astrocytes: autocrine regulation by IL-6 and the soluble IL-6 receptor.
Van Wagoner NJ; Oh JW; Repovic P; Benveniste EN
J Neurosci; 1999 Jul; 19(13):5236-44. PubMed ID: 10377335
[TBL] [Abstract][Full Text] [Related]
6. Role of IL-6 and the soluble IL-6 receptor in inhibition of VCAM-1 gene expression.
Oh JW; Van Wagoner NJ; Rose-John S; Benveniste EN
J Immunol; 1998 Nov; 161(9):4992-9. PubMed ID: 9794436
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of neutrophil-activating chemokines by IL-6 and its soluble receptor isoforms.
McLoughlin RM; Hurst SM; Nowell MA; Harris DA; Horiuchi S; Morgan LW; Wilkinson TS; Yamamoto N; Topley N; Jones SA
J Immunol; 2004 May; 172(9):5676-83. PubMed ID: 15100312
[TBL] [Abstract][Full Text] [Related]
8. Interleukin (IL)-17A synergistically enhances CC chemokine ligand 20 production in IL-1β-stimulated human gingival fibroblasts.
Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T
Hum Immunol; 2012 Jan; 73(1):26-30. PubMed ID: 22019504
[TBL] [Abstract][Full Text] [Related]
9. CCL20 is elevated during obesity and differentially regulated by NF-κB subunits in pancreatic β-cells.
Burke SJ; Karlstad MD; Regal KM; Sparer TE; Lu D; Elks CM; Grant RW; Stephens JM; Burk DH; Collier JJ
Biochim Biophys Acta; 2015 Jun; 1849(6):637-52. PubMed ID: 25882704
[TBL] [Abstract][Full Text] [Related]
10. Cytokine regulation of CC and CXC chemokine expression by human astrocytes.
Oh JW; Schwiebert LM; Benveniste EN
J Neurovirol; 1999 Feb; 5(1):82-94. PubMed ID: 10190694
[TBL] [Abstract][Full Text] [Related]
11. Astrocytes are the major intracerebral source of macrophage inflammatory protein-3alpha/CCL20 in relapsing experimental autoimmune encephalomyelitis and in vitro.
Ambrosini E; Columba-Cabezas S; Serafini B; Muscella A; Aloisi F
Glia; 2003 Feb; 41(3):290-300. PubMed ID: 12528183
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor-like weak inducer of apoptosis increases CC chemokine ligand 20 production in interleukin 1β-stimulated human gingival fibroblasts.
Hosokawa Y; Hosokawa I; Shindo S; Ozaki K; Nakae H; Matsuo T
Hum Immunol; 2012 May; 73(5):470-3. PubMed ID: 22425737
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 6 is autoregulated by transcriptional mechanisms in cultures of rat osteoblastic cells.
Franchimont N; Rydziel S; Canalis E
J Clin Invest; 1997 Oct; 100(7):1797-803. PubMed ID: 9312180
[TBL] [Abstract][Full Text] [Related]
14. IL-9 promotes Th17 cell migration into the central nervous system via CC chemokine ligand-20 produced by astrocytes.
Zhou Y; Sonobe Y; Akahori T; Jin S; Kawanokuchi J; Noda M; Iwakura Y; Mizuno T; Suzumura A
J Immunol; 2011 Apr; 186(7):4415-21. PubMed ID: 21346235
[TBL] [Abstract][Full Text] [Related]
15. CCL20 produced in the cytokine network of rheumatoid arthritis recruits CCR6+ mononuclear cells and enhances the production of IL-6.
Tanida S; Yoshitomi H; Nishitani K; Ishikawa M; Kitaori T; Ito H; Nakamura T
Cytokine; 2009 Aug; 47(2):112-8. PubMed ID: 19535263
[TBL] [Abstract][Full Text] [Related]
16. Regulation of soluble interleukin-6 (IL-6) receptor release from corneal epithelial cells and its role in the ocular surface.
Sugaya S; Sakimoto T; Shoji J; Sawa M
Jpn J Ophthalmol; 2011 May; 55(3):277-282. PubMed ID: 21523377
[TBL] [Abstract][Full Text] [Related]
17. Prolactin enhances basal and IL-17-induced CCL20 production by human keratinocytes.
Kanda N; Shibata S; Tada Y; Nashiro K; Tamaki K; Watanabe S
Eur J Immunol; 2009 Apr; 39(4):996-1006. PubMed ID: 19350575
[TBL] [Abstract][Full Text] [Related]
18. Astrocyte-derived CCL20 reinforces HIF-1-mediated hypoxic responses in glioblastoma by stimulating the CCR6-NF-κB signaling pathway.
Jin P; Shin SH; Chun YS; Shin HW; Shin YJ; Lee Y; Kim D; Nam DH; Park JW
Oncogene; 2018 Jun; 37(23):3070-3087. PubMed ID: 29535421
[TBL] [Abstract][Full Text] [Related]
19. Role of interleukin-6 and soluble IL-6 receptor in region-specific induction of astrocytic differentiation and neurotrophin expression.
März P; Heese K; Dimitriades-Schmutz B; Rose-John S; Otten U
Glia; 1999 May; 26(3):191-200. PubMed ID: 10340760
[TBL] [Abstract][Full Text] [Related]
20. Proinflammatory cytokines synergistically enhance the production of chemokine ligand 20 (CCL20) from rheumatoid fibroblast-like synovial cells in vitro and serum CCL20 is reduced in vivo by biologic disease-modifying antirheumatic drugs.
Kawashiri SY; Kawakami A; Iwamoto N; Fujikawa K; Aramaki T; Tamai M; Arima K; Kamachi M; Yamasaki S; Nakamura H; Tsurumoto T; Kono M; Shindo H; Ida H; Origuchi T; Eguchi K
J Rheumatol; 2009 Nov; 36(11):2397-402. PubMed ID: 19797510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
